GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Belluscura PLC (LSE:BELL) » Definitions » Net Policyholder Benefits/Claims

Belluscura (LSE:BELL) Net Policyholder Benefits/Claims


View and export this data going back to 2021. Start your Free Trial

What is Belluscura Net Policyholder Benefits/Claims?

Net Policyholder Benefits/Claims only applies to insurance companies.


Belluscura (LSE:BELL) Business Description

Traded in Other Exchanges
N/A
Address
15 Fetter Lane, Holborn, London, GBR, EC4A 1BW
Belluscura PLC is a medical device company. Its first product, the X-PLOR, is a lightweight FDA-cleared portable oxygen concentrator designed to replace larger, metal oxygen tanks and heavier portable oxygen concentrator devices. The X-PLO2R weighs less than 1.5kg (3.25 lbs) and it is the first modular portable oxygen concentrator it will generate more oxygen by weight than any other FDA-cleared POC in its class. It either owns or exclusively licenses a total of 26 patents and applications relating to oxygen enrichment devices and treatments.